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Salvia fruticosa Induces 
Vasorelaxation In Rat Isolated 
Thoracic Aorta: Role of the PI3K/
Akt/eNOS/NO/cGMP Signaling 
Pathway
M. Akhtar Anwar  1, Ali A. Samaha2,3, Samar Ballan3, Alaaeldin I. Saleh1, Rabah Iratni4 & Ali 
H. Eid1,5
Salvia fruticosa (SF) Mill. is traditionally used for its antihypertensive actions. However, little is known 
about its pharmacologic and molecular mechanisms of action. Here we determined the effects of an 
ethanolic extract of SF leaves on rings of isolated thoracic aorta from Sprague-Dawley rats. Our results 
show that SF extract increased nitric oxide production and relaxed endothelium-intact rings in a dose-
dependent (0.3 µg/ml–1 mg/ml) manner, and the maximum arterial relaxation (Rmax) was significantly 
reduced with endothelium denudation. Pretreatment of endothelium-intact rings with L-NAME (a 
non-selective inhibitor of nitric oxide synthase, 100 µM), or ODQ (an inhibitor of soluble guanylyl 
cyclase, 10 µM) significantly diminished SF-mediated vasorelaxation. Furthermore, SF induced Akt 
phosphorylation as well as increased cGMP levels in rings treated with increasing doses of SF. Prior 
exposure to PI3K inhibitors, wortmannin (0.1 µM) or LY294002 (10 µM), decreased cGMP accumulation 
and attenuated the SF-induced vasorelaxation by approximately 50% (Rmax). SF-evoked relaxation was 
not affected by indomethacin, verapamil, glibenclamide, tetraethylammonium, pyrilamine or atropine. 
Taken together, our results indicate that SF induces endothelium-dependent vasorelaxation through 
the PI3K/Akt/eNOS/NO/sGC/cGMP signaling pathway. Our data illustrate the health-orientated benefits 
of consuming SF which may act as an antihypertensive agent to reduce the burden of cardiovascular 
complications.
Cardiovascular disease (CVD) remains the leading cause of death in the world1. Along with many other risk 
factors, hypertension continues to be a major contributor to this mortality. Not only does hypertension kill one 
in every eight people, but it also threatens as many as 1 billion people worldwide2. Despite the tremendous thera-
peutic advances made in recent decades, current cardiovascular drugs remain inefficient at treating a significant 
proportion of patients3. Therefore, there is an increasing need for other approaches that could provide new ave-
nues to combat CVD. Especially during the last 10 years, herbal medicine has emerged as a significant alternative 
for the treatment of several diseases including CVD4–6.
Herbs and other medicinal plants have been at the foundation of drug development from the very incep-
tion of global pharmaceutical industry, and continue to attract focus of attention for research, worldwide7, 8. 
Moreover, the public from both developed and developing nations hanker for alternative, cheaper and safer drugs, 
which may be used for prolonged duration with minimal side-effects7. Our knowledge regarding the benefi-
cial constituents of plants, particularly related to ethnomedicine and ethnobotanicals, remains at the stage of 
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infancy. However, the present interest in herbal medicine will certainly lead to an expansion in newer classes of 
botanical-based drugs during the next decade or thereafter. This action is urgently required, as many of the cur-
rently available drugs are not without serious undesired side effects3. Moreover, herbal remedies and their constit-
uents are associated with amelioration of a number of global endemics linked to high morbidities and mortalities, 
including cardiovascular disease5, 6, 9, 10, metabolic syndrome11, 12, cancer13–16 and neurodegenerative diseases17–19.
There are a multitudinous number of medicinal herbs belonging to the genus Salvia (sage). Indeed, sage has a 
worldwide distribution with approximately 1000 species, and is the largest genus in the family Lamiaceae. Several 
species of Salvia have demonstrable physiological and pharmacological attributes associated with improvement 
and prevention in vascular dysfunction, including blood pressure-lowering effects20–24. Interestingly, culinary 
herbs such as sages are important components of diet in the Mediterranean basin, where the demographics of 
cardiovascular-associated morbidity and mortality is low25.
Salvia fruticosa Mill. (Fig. 1) (also referred to as S. libanotica Boiss. & Gaill., S. triloba L.f., and S. cyrpia 
Unger & Kotschy) is commonly known as the East Mediterranean sage and is widely used in the gastronomy 
of the Levant26. It is a perennial herb with trifoliate hairy leaves that are grey to green in color. Its flowers are 
lavender-pinkish in color and are held in a reddish five-pointed hairy calyx27. Accumulating evidence reveals a 
remarkable array of therapeutic properties for this herb. In addition to its many beneficial biological activities in 
its arsenal, sage is also endowed with anti-inflammatory28, anti-oxidant29, 30 and anti-proliferative31 effects, as well 
as the inhibition of smooth muscle contraction32.
Traditionally, as part of the armamentarium of ethnomedicine of the Eastern Mediterranean basin and the 
hinterland beyond, leaves of this herb have been used for their anti-hypertensive effects26, 33. An ethno-botanical 
study has divulged the ethno-pharmaceutical use of Salvia fruticosa Mill. by British Turkish-speaking Cypriots 
residing in London (United Kingdom) for amelioration of high blood pressure (BP)34. Furthermore, in Cyprus, 
the aerial parts of this sage are commonly used for its hypotensive effects35, 36. All of these remedial homeostatic 
effects are bestowed by a rich and diverse population of phytochemicals. The principle quantitative components 
of polyphenols isolated from SF are: hydroxycinnamic acid derivatives: rosmarinic acid (caffeic acid dimer), sal-
vianolic acids (caffeic acid polymers), caffeic acid phenethyl ester (caffeic acid derivative); phenolic diterpenes: 
carnosic acid and carnosol; and flavonoids: luteolin-7-O-glucoside and rutin37, 38. In framework of the present 
study, rosmarinic acid exerts an arterio-relaxant effect in rat isolated thoracic aorta39. Moreover, rosmarinic acid 
was reported to lower BP in fructose-fed hypertensive rats. The drop in BP arose through a mechanism entailing 
a fall in circulating levels of endothelin-1, suppression in angiotensin-converting enzyme activity, and augmen-
tation of nitric oxide synthesis40.
Figure 1. Salvia fruticosa Mill. (Sage). A photograph showing the aerial parts of SF. For medicinal uses, leaves 
are the most commonly consumed part of this plant.
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Despite all these common uses, the mechanism by which this medicinal herb elicits its therapeutic effects on 
the vasculature remains unknown. This study was therefore undertaken to investigate the vasorelaxant function 
of SF in the rat aorta, and to establish the underlying pharmaco-biochemical mechanism of action.
Results
Effect of SF on relaxation of rat isolated aortic rings. First, we determined the vasorelaxing effect of 
SF on endothelium-intact rat aortic rings. Figure 2 provides definitive evidence for SF-induced, dose-dependent 
relaxation of rat isolated aortic rings pre-contracted with norepinephrine, yielding a pED50 value of 4.78 ± 0.08 g/
ml with 95% confidence interval: 4.93–4.63 g/ml, whereas the Rmax is 88 ± 4%. The highest percentage volume of 
vehicle (ethanol) used did not cause a significant relaxation effect on rat aortic ring.
Role of the endothelium in SF-induced relaxation. In this series of experiments, we examined the 
vasorelaxing effect of SF on vascular smooth muscle using endothelium-denuded rat aortic rings. As illustrated in 
Fig. 3, SF induced relaxation in a dose-dependent manner for endothelium-intact and denuded vessels; however, 
removal of the endothelium causes a significant decrease (p < 0.01) in the vasorelaxation produced by SF from 
a dose of 10 µg/ml to 1 mg/ml. The relevant parameter values are: pED50 = 4.78 ± 0.08 g/ml with 95% confidence 
interval: 4.93–4.63 g/ml (with endothelium), 4.76 ± 0.13 with 95% confidence interval: 5.02–4.50 g/ml (without 
endothelium). Similarly, Rmax is 88 ± 4% for endothelium-dependent relaxation and 51 ± 3% for endothelium 
independent relaxation (p < 0.01). It is important to note that while endothelium-dependent relaxation is obvi-
ous, endothelial denudation did not seem to abolish the vasorelaxant effect completely. This suggests that there 
could be an endothelium-independent effect of SF.
Aortic responses to SF in the absence and presence of L-NAME or ODQ. Next, we determined 
the role of nitric oxide and soluble guanylate cyclase in aortic relaxation responses to SF. The SF-induced vaso-
relaxation was significantly attenuated by the presence of L-NAME, an inhibitor of endothelial nitric oxide syn-
thase (Fig. 4A). This confirms a role for NO in SF-induced aortic relaxation. The pED50 values are 4.72 ± 0.07 g/
Figure 2. Effect of SF extract on vasorelaxation of aortic rings. Cumulative dose-dependent curves for SF-
induced relaxation and of the vehicle (ethanol) in rat aortic rings. n = 7.
Figure 3. Role of endothelium in SF-induced relaxation. Cumulative dose-response curves for SF in isolated 
norepinephrine-precontracted rat aortic rings either with intact (+E; triangles) or denuded endothelium (−E; 
squares). n = 7; p < 0.01 for +E versus −E.
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ml with 95% confidence interval: 4.86–4.58 g/ml (without L-NAME), 4.59 ± 0.09 with 95% confidence interval: 
4.78–4.40 g/ml (with L-NAME). Similarly Rmax is 90 ± 4% prior to L-NAME exposure and 52 ± 3% in the pres-
ence of L-NAME (p < 0.01).
In the presence of ODQ (sGC inhibitor, Fig. 4B), the SF-dependent vasorelaxation was significantly inhibited 
by approximately 50%, and there was no change in potency. The pED50 values = 4.76 ± 0.10 g/ml with 95% con-
fidence interval: 4.97–4.55 g/ml (no ODQ exposure) and 4.38 ± 0.37 with 95% confidence interval: 5.14–3.63 g/
ml (with ODQ) to increasing doses of SF-mediated relaxation. Similarly Rmax is 93 ± 6% for ODQ-independent 
relaxation and 48 ± 12% for ODQ-dependent relaxation (p < 0.01).
To further confirm the involvement of NO, rings were incubated with increasing doses of SF and the level of 
NO determined. As shown in Fig. 4C, SF caused a significant and dose-dependent increase in the production of 
nitrate/nitrite, indicative of increased NO production. This suggests that SF elicits its effects via increasing NO 
levels.
Effect of SF on production of cGMP in aortic rings. Since SF-induced vasorelaxation was significantly 
decreased by L-NAME and ODQ, these results suggested we address the question if SF modulates the level of 
cGMP. This nucleotide monophosphate is released from GTP by soluble guanylyl cyclase when nitric oxide 
docks onto its binding domain on the enzyme. Treatment with cumulative doses of SF evoked a significant and 
dose-dependent sigmoidal increase in the production of cGMP (pED50: 4.26 ± 0.14 g/ml; Rmax: 33 ± 5 pmol/mg 
protein) (Fig. 5A). In vehicle-treated rings, the cGMP content was 2.82 ± 0.87 (mean ± SEM) pmole/mg protein. 
However, in rings treated with 0.3 mg/ml SF, the cGMP level was 30.50 ± 3.31 (mean ± SEM) pmole/mg protein 
(p < 0.001).
To confirm if this SF-increased cGMP accumulation is mediated by eNOS and/or sGC, rings were 
pre-treated with either L-NAME (100 µM) or ODQ (1 µM) followed by SF. Indeed, pretreatment with either 
inhibitor significantly inhibited the SF-induced cGMP accumulation (Fig. 5B). Our results also show that 
8-(4-Chlorophenylthio)-guanosine 3′,5′-cyclic monophosphate, a potent and selective activator of cGMP 
dependent protein kinase (PKG), evokes relaxation of aortic rings (data not shown).
Involvement of phosphoinositide 3-kinase(PI3K)/Akt (protein kinase B) signaling path-
way axis in the SF-induced relaxation of aortic rings. The role of PI3K-Akt signaling axis in 
endothelium-dependent aortic relaxation is well-established41, 42. To determine if this signaling cascade is involved 
in the SF-induced relaxation, we utilized two structurally incongruent inhibitors of PI3K, wortmannin and 
LY294002. Indeed, pretreatment with either inhibitor caused a significant decrease in SF-induced vasorelaxation, 
with the maximum relaxation mitigated with no effect on potency. In control rings, pED50 was 4.72 ± 0.08 g/ml 
with 95% confidence interval of 4.89–4.55 g/ml. In wortmannin-preincubated rings, pED50 was 4.29 ± 0.34 with 
95% confidence interval of 4.98–3.60 g/ml. On the other hand, Rmax was 90.0 ± 4.3% for wortmannin-independent 
relaxation and 49.1 ± 11.5% in the presence of wortmannin (p < 0.01, Fig. 6A). Similar results were obtained with 
LY294002 (10 µM) pre-treatment (p < 0.01, Fig. 6B). In LY294002-preincubated rings, pED50 was 4.36 ± 0.13 with 
95% confidence interval of 4.64–4.08 g/ml, and Rmax was 77.4 ± 7.5% for wortmannin-independent relaxation and 
44.5 ± 2.4% in the presence of LY294002.
To further confirm the participation of Akt in the SF-induced vasorelaxant pathway, we determined the level 
of Akt phosphorylation in SF-treated rings that were pre-incubated with or without wortmannin. Indeed, SF 
evoked significant increase in phosphorylation of Akt which was significantly inhibited by wortmannin (n = 3; 
p < 0.05) (Fig. 6C). Furthermore, pre-treatment with tricirbine (10 µM), which selectively inhibits Akt but not 
PI3K, abolished the SF-induced relaxation (data not shown). Taken together, the above data clearly implicates 
activation of the PI3-K/Akt signaling axis in SF-induced aortic relaxation.
Figure 4. Effect of L-NAME or ODQ on SF-induced relaxation. (A) Endothelium-intact rings were incubated 
with cumulative doses of SF in the absence (circles) or presence of L-NAME (100 µM; squares. Data represent 
mean ± SEM (n = 7; p < 0.01 for Salvia versus L-Name plus Salvia). (B) Endothelium-intact rings were 
incubated with cumulative doses of SF in the absence (circles) or presence of ODQ (1 µM; squares). n = 7; 
p < 0.01 for Salvia versus ODQ plus Salvia. (C) Endothelium-intact rings were incubated with increasing doses 
of SF and levels of NO determined. n = 3; *denotes a p < 0.05 and **a p < 0.01 (compared to control).
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To further validate the role of PI3K/Akt cascade in SF-induced relaxation, we pre-incubated rings with wort-
mannin followed by SF treatment and then we assessed cGMP levels. In line with the above results, pre-treatment 
with wortmannin (0.1 µM) significantly abolished SF-induced cGMP accumulation (Fig. 6D)
Role of Potassium Channels in SF-induced relaxation of aortic rings. Increase in the bioavaila-
bility of NO is known to cause vasorelaxation via the activation of calcium-dependent potassium channels43. 
Interestingly, prior inhibition of ATP-dependent or calcium-activated potassium channels caused no effect 
on relaxant responses to SF. Indeed, in vehicle-treated rings, pED50 was 4.77 ± 0.07 g/ml with 95% confidence 
interval of 4.91–4.63 g/ml. Comparable results were obtained with the same rings pre-treated with glibencla-
mide, an ATP-sensitive potassium channels blocker, where pED50 was 4.69 ± 0.17 with 95% confidence interval 
of 5.03–4.34 g/ml. Similarly, Rmax was 93.4 ± 3.8% for inhibitor-independent relaxation and 79.4 ± 7.7% relaxa-
tion in the presence of glibenclamide (p > 0.05) (Fig. 7A). Similar results were obtained when Ca++-activated 
potassium channels were inhibited with tetraethylammonium, TEA (Fig. 7B). In vehicle-treated rings, pED50 
was 4.78 ± 0.1 with 95% confidence interval of 4.98–4.58 g/ml, whereas TEA-pretreatment of the rings produced 
a pED50 value of 4.80 ± 0.15 with 95% confidence interval of 5.10–4.49 g/ml. Similarly, Rmax was 97.9 ± 5.9% for 
inhibitor-independent relaxation and 84.06 ± 6.8% relaxation in the presence of TEA (p > 0.05) (Fig. 7B).
Involvement of calcium channels. To establish if calcium channels participate in SF-induced relaxation, 
we exposed the aortic rings to verapamil, a L-type calcium channel blocker, and there was no significant differ-
ence between the control and treated vessels (p > 0.05) (Fig. 8). In fact, results in vehicle-treated rings (pED50 
was 4.81 ± 0.15 g/ml with 95% confidence interval of 5.11–4.50 g/ml) were similar to verapamil-incubated rings 
(pED50 was 5.03 ± 0.28 with 95% confidence interval of 5.61–4.46 g/ml). Likewise, Rmax was 86.6 ± 7.4% or 
89.5 ± 11.5% in the absence or presence of verapamil, respectively (Fig. 8).
Involvement of cyclooxygenases. Prostanoids are known to regulate vascular tone44, 45. Here, we 
show that indomethacin, a non-selective cyclooxygenase blocker, did not significantly alter relaxant responses 
of rat aortic rings to SF (p > 0.05). Indeed, in salvia-treated rings, pED50 was 4.78 ± 0.10 g/ml with 95% confi-
dence interval: 4.98–4.58 g/ml. And in indomethacin-treated rings, pED50 was 4.75 ± 0.11 g/ml with 95% con-
fidence interval of 4.97–4.53 g/ml. Similarly Rmax is 89.3 ± 4.6% for untreated relaxation and 82.4 ± 4.7% for 
indomethacin-exposed relaxation (Fig. 9).
Involvement of histaminergic or muscarinic receptors. Penultimately, we investigated the influence 
of pyrilamine, a blocker of histamine H1-receptors on SF-generated aortic relaxation. In rings treated with salvia 
alone, pED50 was 4.84 ± 0.13 g/ml with 95% confidence interval of 5.11–4.57 g/ml. These results are analogous 
to those obtained in the presence of pyrilamine, where pED50 was 5.06 ± 0.15 with 95% confidence interval of 
5.36–4.76 g/ml, to increasing doses of SF-mediated relaxation. Similarly, Rmax is 85 ± 6% for rings treated with 
salvia alone, versus92 ± 6% for pyrilamine exposed ones, Fig. 10A). Pyrilamine did not have a significant effect 
on SF-induced relaxation (p > 0.05).
Figure 5. Modulation of cGMP levels by SF, L-NAME and ODQ. (A) Rings were incubated in the absence 
(control) or presence of increasing concentrations of SF. cGMP immunoassay followed and levels of cGMP 
were determined. n = 6; *denotes a p < 0.05, **a p < 0.01 and ***a p < 0.001 compared to control. (B) Rings 
were pretreated for 30 minutes with L-NAME (100 µM) or ODQ (1 µM) followed by SF (0.67 mg/ml) and cGMP 
levels determined. n = 5; **denotes a p < 0.01 compared to control; ##denotes a p < 0.01 compared to SF).
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Lastly, we also determined the effect of atropine, a natural alkaloid that acts as a non-selective blocker of mus-
carinic receptors. In control rings, pED50 value was 4.82 ± 0.14 g/ml with 95% confidence interval of 5.11–4.54 g/
ml. By comparison, in atropine-treated rings, pED50 was 4.75 ± 0.13 with 95% confidence interval of 5.01–4.49 g/
ml to increasing doses of SF-mediated relaxation. Similarly, Rmax is 86 ± 6% for inhibitor-independent relaxation 
and 82 ± 6% for atropine-treated relaxation, and magnitude of maximal relaxation is similar in both groups, 
Fig. 10B). Therefore, atropine does not have any significant effect on SF-induced relaxation (p > 0.05).
Discussion
The objective of the current experiments was to determine the pharmacological effects of ethanolic extract of 
Salvia fruticosa Mill. leaves on rat isolated thoracic aorta. From these observations, the salient feature of our 
investigation points to the key role of the PI3K/Akt, endothelial nitric oxide synthase, nitric oxide, soluble guany-
lyl cyclase and cGMP pathway (Fig. 11). To our knowledge, this is the first investigation to examine the detailed 
effects of extracts from any Salvia species activating the PI3K through to cGMP pathway. Additionally,our results 
show that the dose-dependent relaxation responses to S. fruticosa Mill. are contingent on endothelial cells. This 
is reflected by the observations that relaxation was significantly diminished both upon denudation of luminal 
endothelial layer and by inhibition of eNOS by L-NAME.
Figure 6. Interplay between SF and PI3K pathway. Endothelium-intact rings were incubated with cumulative 
doses of SF in the absence (triangles) or presence of PI3K inhibitors: (A) Wortmannin (0.1 µM; squares) or (B) 
LY29400 (10 µM; squares). Data represent mean ± SEM (n = 5; p < 0.01 for Salvia versus Wortmannin + Salvia 
or LY29400 + Salvia). (C) Modulation of Akt phosphorylation by SF. Aortic rings were incubated in either the 
absence (veh) or presence of wortmannin (wort) for 30 minutes. Rings were then pre-contracted with NE (3 µM) 
followed by treatment with SF (0.67 mg/ml) for 15 minutes. Proteins were extracted and subjected to SDS-PAGE 
against phosphorylated and total Akt levels. Bar graph represents normalization of the phosphorylated Akt 
levels to total ones. Bars with similar letters are significantly different; p < 0.05); n = 4 rings. (D) Rings were 
incubated with or without SF (0.67 mg/ml) after having been pre-treated without (vehicle) or with wortmannin 
(wort; 0.1 µM) for 30 minutes. Then, cGMP levels were determined. n = 5; *denotes a p < 0.05.
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In native, healthy endothelia, there is a choreographed balance between the actions of vasoconstrictors 
(pro-inflammatory) and vasodilators (anti-inflammatory). When this equilibrium is shifted, a derangement in 
vascular homeostasis ensues. The vascular dysfunction of the arterial tree is a prelude to hypertension. Ample 
evidence exists to support the notion of vascular abnormalities (functional, mechanical and structural – vascular 
remodeling) in hypertension affecting not only small vessels, but also large calibre arteries5, 6, 46–48. Moreover, the 
homeostatic disturbance results in augmentation of vascular tone, activation of inflammatory responses, prolif-
eration of VSMCs, and eventually precipitates an atherothrombogenic milieu9, 49, 50. Hence, a healthy life-style, 
embracing the intake of protective nutrients, such as S. fruticosa Mill., is imperative to ensure that endothelial cell 
homeostasis is optimally maintained.
The endothelium plays a critical role in determining vasotone, and receptors located on the endothelial surface 
are primary targets for initiating vasodilatory effects51 Activation of muscarinic M3 subtype52 and histaminergic 
H153 receptors will induce relaxation of blood vessels. From our observations, we can conclude that SF–induced 
aortic relaxation is not mediated by muscarinic or histaminergic receptors. Accordingly, these results are consist-
ent with a previous work showing their lack of involvement in relaxant effect of Danshen on rat isolated femoral 
arteries54.
Stimulation of the PI3K/Akt signaling pathway axis triggers a network of multiple outcomes. Accumulated 
evidence shows PI3K phosphorylates Akt at Ser473 causing the kinase to be activated, and to mediate down-
stream signaling processes associated with cell growth and migration44, 55–58, but has also been implicated in 
endothelium-dependent relaxation41, 42. More pertinently, eNOS has been found to be activated via the PI3K/
Akt pathway by natural compounds like epigallocatechin-3-gallate59. Recently, in an ischemia/reperfusion injury 
Figure 7. Role of potassium channels in SF-induced relaxation of aortic rings. Endothelium-intact rings were 
incubated with cumulative doses of SF in the absence (Salvia plus vehicle; filled circles) or presence of (A) 10 µM 
of Glibenclamide (Glib + Salvia; squares), or (B) Tetraethylammonium (100 µM) (TEA + Salvia; triangles). 
n = 6 or 5 for glibenclamide or TEA experiments, respectively. In both cases, no difference was noted between 
inhibitor treated and vehicle administered curves; p > 0.05 for Salvia alone versus either Glib + Salvia or 
Salvia + TEA.
Figure 8. Role of Calcium Channels in SF-induced relaxation of aortic rings. Endothelium-intact rings 
were incubated with cumulative doses of SF in the absence (Salvia; circles) or presence of verapamil (1 µM; 
verap + Salvia; squares). n = 5; p > 0.05.
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model, it was found that ginsenosides, the major bioactive components of species panax ginseng, increase coro-
nary arterial flow through stimulation of PI3K/Akt/eNOS mechanistic route. This demonstrates that the appli-
cation of isolated extracts of ginseng bestowed protection against myocardial damage60. Similarly, in another 
study, activation of PI3K/Akt/NO pathway by the principle metabolite of ginsenosides evoked cardioprotection 
in myocardial ischemia-reperfusion injury61.
Stimulation of Akt enhances the activity of eNOS by phosphorylating serine at 117762, 63. This, in turn, triggers 
increased release of nitric oxide (NO)62–64. NO then diffuses from the endothelial layer to the VSMCs wherein it 
activates the soluble guanylyl cyclase (sGC). Active sGC catalyzes the subsequent conversion of GTP to cGMP, 
which phosphorylates protein kinase G (PKG), a major intermediary in the vasorelaxation process45. Evidently, 
the results of our SF-induced aortic relaxation and dissection of its endothelium-reliant mechanistic route com-
plements the aforementioned signaling mechanism through the PI3K/Akt/eNOS/NO/cGMP pathway. Notably, 
of all the Salvia species examined to date, this is the first study to show vasorelaxant effect from PI3K to cGMP 
in healthy normotensive vessels. In a corresponding manner, our results are in accord with a previous report 
demonstrating that extracts from the species Salvia miltiorrhiza (the dried root of which is commonly known 
Figure 9. Role of cyclooxygenases in SF-induced relaxation of aortic rings. Endothelium-intact rings were 
incubated with cumulative doses of SF in the absence (Salvia; circles) or presence of indomethacin (10 µM; 
Indo + Salvia; squares). Data represent mean ± SEM (n = 5; p > 0.05).
Figure 10. Involvement of histaminergic or muscarinic receptors in SF-induced vasorelaxation. Endothelium-
intact rings were exposed to cumulative doses of SF in the absence (Salvia; circles) or presence of (A) 10 µM of 
pyrilamine (pyrilamine + Salvia; squares), or (B) 10 µM of atropine (atropine + Salvia; squares). Data represent 
mean ± SEM (n = 6 or 5 for pyrilamine or atropine experiments, respectively). p > 0.05 for Salvia alone versus 
either pyrilamine + Salvia or Salvia + atropine.
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as danshen) evoked endothelium-dependent relaxation that was reliant on NO and cGMP in rat aortic heli-
cal strips21. Conversely, endothelium-independent relaxation of rat coronary arteries responding to an aqueous 
extract of danshen has also been reported65.
Nitric oxide, a gaso-transmitter, is not only a potent vasodilator66–68, but also demonstrates antagonistic prolif-
erative and thrombogenic behavior69. This endogenous intervention ensures vasculoprotection of the circulatory 
network by promoting homeostatic blood flow. In contrast, diminished NO bioavailability leads to a derangement 
in vasodilatory control, resulting in the onset and progression of hypertension as well as atherosclerosis among 
other vascular pathologies49.
Potassium channels play a critical role in regulating plasma membrane potential, and hence determining 
vascular tone70, 71. Increased bioavailability of nitric oxide is known to activate calcium-gated potassium chan-
nels43, which induce vasorelaxation by a mechanism involving hyperpolarization72. Our results suggest that nei-
ther Ca2+-dependent nor ATP-driven potassium channels are involved in SF-induced aortic relaxation. On the 
other hand, tanshinone IIA (a lipophilic diterpene quinone isolated from danshen) activates ATP-dependent 
potassium channels to decrease intracellular calcium concentration in rat aortic smooth muscle cells, and lead-
ing to relaxation73. Similarly, by using a 1000-fold higher concentration of TEA (100 mM) than that adminis-
tered in the present study (100 µM), other researchers have demonstrated that danshen-induced participation 
of TEA-responsive potassium channels in endothelium-independent relaxation of rat coronary arteries65. These 
examples clearly illustrate the dichotomy in the members of genus Salvia, possibly due to differences in phyto-
chemical profiles. Interestingly, ginsenoside-Re, a constituent of Panax ginseng, activates PI3K/Akt and NO sig-
naling network to promote the opening of Ca2+-stimulated potassium channels in aortic smooth muscle cells74. 
The discrepancy that exists between our results and those outlined from the three different groups of investiga-
tors may be explained by highlighting the interplay of multiple contributory factors. Namely, disparity in Genus 
(Salvia versus Panax), dissimilarity in Saliva species (fruticosa versus miltiorrhiza), as well as the differences in 
parts of the plant (root versus leaves), each of these attributes will likely yield a highly variable phytochemical fin-
gerprint. In this regard, some phytochemicals are exclusive to danshen (such as lipophilic tanshinones), whereas 
other constituents may share a commonality between the botanicals. An important point to take into account is 
that the concentration of each component will be highly variable due to location of harvesting, soil conditions, 
weather and time of harvest (season). In addition, there are methodological differences, for instance the applied 
concentration of antagonists (as is the case with TEA discussed above), extraction solvent and concentration of 
the herbal extract, and location of segment of vessel acquired from the arterial network (aorta versus coronary 
artery) will all contribute to disparity between the results.
Our data reveal that Ca2+ channels do not contribute to SF-induced relaxation of rat aortas. Interestingly, the 
blockage of calcium channels by danshen induces endothelium-independent relaxant activity in rat coronary 
arteries65. While this may appear to conflict with our study, it is important to note that different vascular beds 
Figure 11. Schematic representation of the mechanism of Salvia fruticosa-induced relaxation of rat isolated 
aorta. The diagram displays the central role of nitric oxide, and its upstream activators and downstream 
effectors. Pharmacologic inhibitors are shown in red font color. Blue crosses reveal no involvement in the 
mechanism of SF-induced relaxation. The pathways for SF mechanism of action are drawn in black arrows.
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behave differently even to the same stimulus75, 76. This apparent difference in response may also be explained by 
the points discussed above.
Cyclooxygenases (isoforms COX-1 and COX-2) are crucial enzymes in the conversion of arachidonic acid 
to biologically active prostanoids. This group of lipophilic compounds is known to play multiple roles in vascu-
lar biology, including vasodilation67, 77. One such potent vasodilator released by the endothelium is prostacyc-
lin (PGI2), which acts via its corresponding G-protein coupled hepta-helical transmembrane domain receptors 
(IP)78. As a matter of fact, in the present investigation, the cyclooxygenase pathway does not appear to participate 
in SF-mediated relaxant activity. This concurs with an earlier report of a non-contributory function of prosta-
glandins to danshen-induced relaxant responses in rat femoral arteries54. This is not surprising as both herbs, 
danshen79 and SF37, are characterized by the presence of rosmarinic acid. More to the point, rosmarinic acid is a 
non-selective inhibitor of the enzyme isoforms COX-1 and COX-280. Furthermore, the authors highlighted the 
property of inhibitory activity being comparable to the non-steroidal anti-inflammatory drugs (NSAIDs), aspirin, 
ibuprofen and naproxen80. Apparently, SF will be unable to recruit the prostanoid metabolites for regulation of 
vascular tone.
The molecular mechanism of action for SF in rat aorta is summarized in Fig. 11. Collectively, our investi-
gation supports the health orientated benefits of SF as a vasodilator. All blood vessels contribute to the overall 
systemic resistance and consequent blood pressure. The aorta itself affects and is affected by changes in blood 
pressure. However, it is the resistance vessels that impart the biggest effect on vascular resistance. Therefore, the 
present studies are to be extended to resistance-size arteries (<300 µm internal diameter). If the results from 
these microvessels mirrored those obtained from aortic vessels, then this would confirm the potential for SF as 
a regulator for blood pressure. These studies may underscore and provide concrete confirmation for what we 
have observed in a large conduit vessel; and raison d’etre for its inclusion in ethnomedicine cabinet pertaining 
to inhabitants of the Levant. As such, these future investigations could substantiate the notion of Salvia fruticosa 
Mill. as an anti-hypertensive agent.
Materials and Methods
Preparation of the extract. Leaves of Salvia fruticosa Mill. were harvested from Yanouh area (East of Tyre, 
Lebanon) (GPS coordinates: 33°15′52 N and 35°17′53 E). No specific permission is required for collecting this 
plant or for using the land where it is located. This plant is neither an endangered nor a protected species; it is 
readily and commercially available in the market.
The SF extract was prepared as in our recent publications of two other herbs16, 81, 82. Leaves were rinsed in 
distilled water to remove any dust or dirt and air-dried in the dark at room temperature. After grinding the leaves 
with a mortar and pestle, the powder was extracted three times in 70% aqueous ethanol and the mixture kept in 
the dark for 72 hours at 4 degrees without stirring. The mixture was then filtered through a sintered glass funnel 
and the filtrate evaporated to dryness using rotary evaporator at room temperature. The obtained residue was 
collected and kept at −20 °C until further use, when it would be dissolved in aqueous ethanol.
Preparation of rat isolated thoracic aortae. Ethics Statement. All procedures used within the pres-
ent study were performed in strict compliance with the recommendations in the Guide for the Care and Use of 
Laboratory Animals of the National Institutes of Health. Institutional approval was obtained for all protocols and 
procedures (Scientific Committee in the Faculty of Public Health in the Lebanese University; (Permit number for 
Samaha Salvia Project: UL/FSPIV/07/2011)). All efforts were made to minimize suffering.
Animals. Experiments in this study were conducted on male Sprague-Dawley rats weighing 230–290 gm. 
Animals were kept under a 12:12 hours light: dark cycle at a temperature of 23 ± 2 °C and had access to food and 
water ad libitum.
Drugs and Chemicals. Norepinephrine, 3-isobutyl-1-methylxanthine (IBMX), acetylcholine, 
Nω-nitro-L-arginine methyl ester (L-NAME), atropine, pyrilamine, verapamil, indomethacin, tetraethylammo-
nium (TEA), 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) were purchased from Sigma-Aldrich Co. 
(St. Louis, MO, USA). Wortmannin and LY294002 were obtained from Alexis Biochemicals (USA) and Tocris 
(USA), respectively.
Quantification of NO production. As we recently described82, NO production was determined by cal-
culating the amount of nitrate/nitrite produced based on the Griess reaction. A colorimetric assay kit (Cayman 
Chemicals, Michigan, USA) was used as per the manufacturer’s instructions83. Briefly aortic homogenates and 
Griess reagents were mixed and incubated at room temperature for 10 min and the absorbance was measured at 
540 nm wavelength. The amount of nitrite formed was normalized to the protein content of the respective aortic 
rings. A standard curve was constructed using known concentrations of sodium nitrite. The absorbance value of 
blank wells were subtracted from the values of the wells with the rings.
Preparation of Aortic Rings and Tension Measurement. On the day of experimentation, the animals 
were euthanized by an overdose of phenobarbital (50 mg/kg body weight) and the thoracic aorta was rapidly 
dissected and isolated, and placed in cold (4 °C) modified Krebs-Henseleit buffer (KHB) pre-equilibrated with 
5% CO2 in oxygen. The aorta was carefully cleaned of adhering connective and fat tissues, and cut into ring seg-
ments of 2 to 3 mm in length. Each aortic ring was suspended by a pair of stainless steel hook (stationary) and 
stirrup (attached to isometric force transducer) in a pre-warmed (37 ± 2 °C) organ bath chamber containing a 
modified Krebs-Henseleit buffer (KHB, pH 7.4, 37 ± 2 °C) with the composition previously described84 (mM): 
NaCl (130), Mg2SO4·7H2O (1.17), NaHCO3 (14.9), KCl (4.7), KH2PO4 (1.18), CaCl2·2H2O (1.6) and glucose 
(5.5). This solution was aerated with 95% O2 and 5% CO2 to maintain the pH of KHB at 7.4. During the initial 
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equilibration period of 1 hr, the rings were subjected to isometric resting tension of 2 g in a step-wise manner as 
previously described85. Aortic ring tension responses were recorded by a computerized data acquisition system 
(AD Instruments, UK) and Chart software (AD Instruments, UK). Subsequently, the vessel integrity was deter-
mined by application of 3 µM NE, followed by 2 exposures to 80 mM KCl, with thorough washes with KHB in 
between each activation of the aorta. If the tension recordings to the two KCl challenges were similar, the proto-
cols below were followed.
Experimental protocols. Endothelium-intact aortic rings were precontracted with norepinephrine (NE) 
(3 µM). Cumulative concentrations (0.3 µg/ml to 1 mg/ml, at half-log doses) of SF were added to determine the 
rings’ reactivity. At each dose of SF, the curve was allowed to reach a plateau before the addition of subsequent 
dose. To ensure that integrity of the endothelium was maintained, vascular relaxant response to Ach (10 µM) was 
assessed in each vessel following precontraction with NE (>80% relaxation of NE-dependent contraction). When 
the involvement of the endothelium in the observed relaxation was desired, vessels were denuded of the endothe-
lial layer. Failure of Ach to produce a vasorelaxant response greater than 25% was assumed as an indication of 
effective endothelium denudation. Cumulative dose response curves (0.3 µg/ml to 1 mg/ml, at half-log doses) of 
SF were then determined in these endothelial-stripped rings.
The concentrations of inhibitors/antagonists used in the proceeding experiments have already been described 
previously86, each blocker was incubated for 30 min as appropriate, and followed SF’s ability to relax aortic seg-
ments. The solvents used for dissolving the blockers are indicated below (following each inhibitor). None of the 
vehicles/solvents used has any vasorelaxing effects on its own at all the doses used.
To determine the role of NO, rings with intact endothelium were pretreated with L-NAME (100 μM), a nitric 
oxide (NO) synthase inhibitor, for 30 minutes. Then, aortic rings were contracted with NE, followed by treatment 
with SF.
To investigate the role of guanylate cyclase, prostaglandins, potassium channels, muscarinic receptors, hista-
mine H1-receptors or calcium channels in SF-induced relaxation, the following inhibitors were used: oxadiazole 
quinoxalin (ODQ, 10 µM), a soluble guanylate cyclase inhibitor; Indomethacin (10 µM), a non-selective cyclooxy-
genase inhibitor; Glibenclamide (10 µM), an ATP-sensitive potassium channels blocker, or Tetraethylammonium 
(100 µM), a non-selective inhibitor of Ca++-activated potassium channels; pyrilamine (10 μM), a histamine 
H1-receptor antagonist or atropine (10 μM), a muscarinic receptor antagonist; and Verapamil hydrochloride 
(1 µM), a L-type Calcium channel blocker.
The role of the PI3K/Akt signaling was assessed by pre-incubating the rings with wortmannin (100 nM) or 
LY294002 (10 µM) for 30 minutes. This was followed by cumulative dose response curve for treatments with SF.
To validate that no significant irreversible or residual effect on vascular responsiveness to SF extract has taken 
place, the aortic rings that had been exposed to cumulative concentrations of SF were washed for 45 to 60 min-
utes, followed by new exposure to NE (3 μM) and Ach (10 μM). Finally, the rings were challenged again with KCl 
(80 mM) to confirm the viability of the vessels.
cGMP assay. Pre-equilibrated rings were incubated in 3-isobutyl-1-methylxanthine (IBMX, a competitive 
nonselective phosphodiesterase inhibitor; 0.1 mM) for 30 minutes before addition of NE. Vessels were then 
allowed to equilibrate for an additional 30 minutes before addition of SF. The reaction was then quickly stopped 
by freezing the tissues in liquid nitrogen. After homogenization in trichloroacetic acid, samples were centrifuged 
at 10000 × g for 10 min and the supernatant was extracted five times with water-saturated diethylether. The cGMP 
and protein content in the extract were determined by a specific immunoassay (Amersham Biosciences (now GE 
Healthcare Life Sciences), USA) and by the use of Bradford’s method, respectively. Results are expressed as pmoles 
of cGMP per milligram of protein.
Western blotting. Rings were homogenized in a sample buffer containing 2% SDS and 60 mM Tris ⋅ HCl 
(pH = 6.8) at room temperature. After clearing the homogenate by centrifugation (14,000 g, 10 min, 4 °C), the 
supernatant was collected. Protein concentrations were determined using the bincinchoninic acid assay (Pierce). 
Equal amounts of proteins were loaded and resolved on a 10% sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) and transferred to polyvinyldifluoride membrane (Millipore). After blocking with 10% 
nonfat dry milk in Tris-buffered saline containing 0.1% Tween 20, membranes were washed then incubated with 
primary antibodies for total or phosphorylated Akt (Cell Signaling, USA) at 4 °C, overnight. The membrane was 
then washed three times and incubated with HRP-conjugated secondary antibody for 1 hour. After extensive 
washings, blots were developed using enhanced chemiluminescence (Amersham Biosciences, USA).
Statistical analysis. Data are presented as means ± SEM. Relaxations to SF are expressed as a percentage 
decrease of the NE contraction. Each cumulative dose-effect curve for SF-induced relaxation was plotted, con-
tingent on application of sigmoidal curve fitting and non-linear regression, using Prism version 6 (GraphPad 
Software Inc., San Diego, CA., U.S.A.) to generate the parameters Rmax (maximal relaxant response) and pED50 
(the negative logarithm of SF dose required to give 50% of the maximum aortic-relaxant response, Rmax). 
Statistical analysis of the data was performed by Student’s t-test. When more than two means were compared, 
Analysis of Variance (ANOVA) was used: either a one-way ANOVA with Tukey’s post hoc test (data represented 
as bar graphs) or a two-way ANOVA with Sidak’s multiple comparison post hoc test (data represented as sigmoi-
dal curves) (Prism, GraphPad Software, San Diego, CA). A p value of less than 0.05 was considered statistically 
significant.
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